Abortion drug gets FDA warning

NEWS IN BRIEF — Posted Aug. 8, 2005

Print  |   Email  |   Respond  |   Reprints  |   Like Facebook  |   Share Twitter  |   Tweet Linkedin

The Food and Drug Administration is warning physicians to be alert to the possibility that patients undergoing medical abortion using mifepristone may develop sepsis, particularly if the drug is not used in accordance with the labeling.

"We believe it is important to share with health care providers and patients the latest serious reports of infection associated with this drug that we have received," said Steven Galson, MD, MPH, acting director of the agency's Center for Drug Evaluation and Research.

From September 2003 until June 2005, the agency recorded four deaths due to sepsis following a medical abortion. The agency is particularly concerned because symptoms in these cases were unusual for sepsis and linked to a bacterium, Clostridium sordelli, that rarely causes illness.

Sepsis is a known risk of any type of abortion. The agency has not conclusively linked these cases to the use of the drug.

Note: This item originally appeared at

Back to top



Read story

Confronting bias against obese patients

Medical educators are starting to raise awareness about how weight-related stigma can impair patient-physician communication and the treatment of obesity. Read story

Read story


American Medical News is ceasing publication after 55 years of serving physicians by keeping them informed of their rapidly changing profession. Read story

Read story

Policing medical practice employees after work

Doctors can try to regulate staff actions outside the office, but they must watch what they try to stamp out and how they do it. Read story

Read story

Diabetes prevention: Set on a course for lifestyle change

The YMCA's evidence-based program is helping prediabetic patients eat right, get active and lose weight. Read story

Read story

Medicaid's muddled preventive care picture

The health system reform law promises no-cost coverage of a lengthy list of screenings and other prevention services, but some beneficiaries still might miss out. Read story

Read story

How to get tax breaks for your medical practice

Federal, state and local governments offer doctors incentives because practices are recognized as economic engines. But physicians must know how and where to find them. Read story

Read story

Advance pay ACOs: A down payment on Medicare's future

Accountable care organizations that pay doctors up-front bring practice improvements, but it's unclear yet if program actuaries will see a return on investment. Read story

Read story

Physician liability: Your team, your legal risk

When health care team members drop the ball, it's often doctors who end up in court. How can physicians improve such care and avoid risks? Read story

  • Stay informed
  • Twitter
  • Facebook
  • RSS
  • LinkedIn